Yayın Bilgisi Atıf Sayısı Adres
1 Karabey-Akyurek, Y; Nemutlu, E; Bilensoy, E; Oner, L, “An Improved and Validated HPLC Method for the Determination of Methylprednisolone Sodium Succinate and its Degradation Products in Nanoparticles”, CURR PHAR A, Cilt 13, Baskı 2, Sayfa 162-168, 2017wos wos 0 hacettepe
2 Varan, G; Oncul, S; Ercan, A; Benito, JM; Mellet, CO; Bilensoy, E, “Cholesterol-Targeted Anticancer and Apoptotic Effects of Anionic and Polycationic Amphiphilic Cyclodextrin Nanoparticles”, J PHARM SCI, Cilt 105, Baskı 10, Sayfa 3172-3182, 2016wos wos 0 hacettepe
3 Erdogar, N; Esendagli, G; Nielsen, TT; Sen, M; Oner, L; Bilensoy, E, “Design and optimization of novel paclitaxel-loaded folate-conjugated amphiphilic cyclodextrin nanoparticles”, INT J PHARM, Cilt 127, Baskı 1, Sayfa 375-390, 2016wos wos 0 hacettepe
4 Aktas, Y; Yenice, K; Bilensoy, E; Hincal, AA, “Amphiphilic cyclodextrins as enabling excipients for drug delivery and for decades of scientific collaboration: Tribute to a distinguished scientist, French representative and friend – A historical perspective”, J DRUG DELI, Cilt 30, Baskı 0, Sayfa 261-265, 2015wos wos 0 hacettepe
5 Erdogar, N; Iskit, AB; Eroglu, H; Sargon, MF; Mungan, NA; Bilensoy, E, “Antitumor Efficacy of Bacillus Calmette-Guerin Loaded Cationic Nanoparticles for Intravesical Immunotherapy of Bladder Tumor Induced Rat Model”, J NANOSCI N, Cilt 15, Baskı 12, Sayfa 10156-10164, 2015wos wos 0 hacettepe
6 Unal, H; d’Angelo, I; Pagano, E; Borrelli, F; Izzo, A; Ungaro, F; Quaglia, F; Bilensoy, E, “Core-shell hybrid nanocapsules for oral delivery of camptothecin: formulation development, in vitro and in vivo evaluation”, J NANOPAR R, Cilt 17, Baskı 1, Sayfa 0-0, 2015wos wos 0 hacettepe
7 Unal, H; Ozturk, N; Bilensoy, E, “Formulation development, stability and anticancer efficacy of core-shell cyclodextrin nanocapsules for oral chemotherapy with camptothecin”, BEIL J OR C, Cilt 11, Baskı 0, Sayfa 204-212, 2015wos wos 1 hacettepe
8 Varan, C; Bilensoy, E, “Development of implantable hydroxypropyl-beta-cyclodextrin coated polycaprolactone nanoparticles for the controlled delivery of docetaxel to solid tumors”, J INCL P MA, Cilt 80, Baskı 1, Sayfa 9-15, 2014wos wos 2 hacettepe
9 Vranic, E; Grizic, D; Planinsek, O; Srcic, S; Bilensoy, E, “Binary, ternary and microencapsulated celecoxib complexes with beta-cyclodextrin formulated via hydrophilic polymers”, J INCL P MA, Cilt 80, Baskı 1, Sayfa 139-146, 2014wos wos 1 hacettepe
10 Erdogar, N; Iskit, AB; Eroglu, H; Sargon, MF; Mungan, NA; Bilensoy, E, “Cationic core-shell nanoparticles for intravesical chemotherapy in tumor-induced rat model: Safety and efficacy”, INT J PHARM, Cilt 127, Baskı 1, Sayfa 1-9, 2014wos wos 3 hacettepe
11 Erdogar, N; Iskit, AB; Mungan, NA; Bilensoy, E, “Prolonged retention and in vivo evaluation of cationic nanoparticles loaded with Mitomycin C designed for intravesical chemotherapy of bladder tumours”, J MICROENC, Cilt 29, Baskı 6, Sayfa 576-582, 2012wos wos 7 hacettepe
12 Karakas, FP; Karakas, A; Boran, C; Turker, AU; Yalcin, FN; Bilensoy, E, “The evaluation of topical administration of Bellis perennis fraction on circular excision wound healing in Wistar albino rats”, PHARM BIOL, Cilt 50, Baskı 8, Sayfa 1031-1037, 2012wos wos 8 hacettepe
13 Bilensoy, E; Moroy, P; Cirpanh, Y; Bilensoy, T; Calis, S; Mollamahmutoglu, L, “A double-blind placebo-controlled study of 5-fluorouracil:cyclodextrin complex loaded thermosensitive gel for the treatment of HPV induced condyloma”, J INCL P MA, Cilt 69, Baskı 3, Sayfa 309-313, 2011wos wos 2 hacettepe
14 Cirpanli, Y; Allard, E; Passirani, C; Bilensoy, E; Lemaire, L; Calis, S; Benoit, JP, “Antitumoral activity of camptothecin-loaded nanoparticles in 9L rat glioma model”, INT J PHARM, Cilt 403, Baskı 1, Sayfa 201-206, 2011wos wos 36 hacettepe
15 Rouf, MA; Vural, I; Bilensoy, E; Hincal, A; Erol, DD, “Rapamycin-cyclodextrin complexation: improved solubility and dissolution rate”, J INCL P MA, Cilt 70, Baskı 1, Sayfa 167-175, 2011wos wos 9 hacettepe
16 Yavuz, B; Bilensoy, E; Vural, I; Sumnu, M, “Alternative oral exemestane formulation: Improved dissolution and permeation”, INT J PHARM, Cilt 398, Baskı 1, Sayfa 137-145, 2010wos wos 18 hacettepe
17 Cirpanli, Y; Yerlikaya, F; Ozturk, K; Erdogar, N; Launay, M; Gegu, C; Leturgez, T; Bilensoy, E; Calis, S; Capan, Y, “Comparative evaluation of in vitro parameters of tamoxifen citrate loaded poly(lactide-co-glycolide), poly(epsilon-caprolactone) and chitosan nanoparticles”, PHARMAZIE, Cilt 65, Baskı 12, Sayfa 867-870, 2010wos wos 4 hacettepe
18 Bilensoy, E, “Cationic nanoparticles for cancer therapy”, EXP OP DR D, Cilt 7, Baskı 7, Sayfa 795-809, 2010wos wos 26 hacettepe
19 Bilensoy, E; Hincal, AA, “Recent advances and future directions in amphiphilic cyclodextrin nanoparticles”, EXP OP DR D, Cilt 6, Baskı 11, Sayfa 1161-1173, 2009wos wos 34 hacettepe
20 Cirpanli, Y; Bilensoy, E; Dogan, AL; Calis, S, “Comparative evaluation of polymeric and amphiphilic cyclodextrin nanoparticles for effective camptothecin delivery”, EUR J PH B, Cilt 73, Baskı 1, Sayfa 82-89, 2009wos wos 53 hacettepe
21 Cakmak, A; Cirpanli, Y; Bilensoy, E; Yorganci, K; Calis, S; Saribas, Z; Kaynaroglu, V, “Antibacterial activity of triclosan chitosan coated graft on hernia graft infection model”, INT J PHARM, Cilt 381, Baskı 2, Sayfa 214-219, 2009wos wos 17 hacettepe
22 Bilensoy, E; Sarisozen, C; Esendagli, G; Dogan, AL; Aktas, Y; Sen, M; Mungan, NA, “Intravesical cationic nanoparticles of chitosan and polycaprolactone for the delivery of Mitomycin C to bladder tumors”, INT J PHARM, Cilt 371, Baskı 1, Sayfa 170-176, 2009wos wos 56 hacettepe
23 Bilensoy, E; Gurkaynak, O; Dogan, AL; Hincal, AA, “Safety and efficacy of amphiphilic beta-cyclodextrin nanoparticles for paclitaxel delivery”, INT J PHARM, Cilt 347, Baskı 1, Sayfa 163-170, 2008wos wos 74 hacettepe
24 Yenice, I; Mocan, MC; Palaska, E; Bochot, A; Bilensoy, E; Vural, I; Irkec, M; Hincal, AA, “Hyaluronic acid coated poly-epsilon-caprolactone nanospheres deliver high concentrations of cyclosporine A into the cornea”, EXP EYE RES, Cilt 87, Baskı 3, Sayfa 162-167, 2008wos wos 40 hacettepe
25 Bilensoy, E; Gurkaynak, O; Ertan, M; Sen, M; Hincal, AA, “Development of nonsurfactant cyclodextrin nanoparticles loaded with anticancer drug paclitaxel”, J PHARM SCI, Cilt 97, Baskı 4, Sayfa 1519-1529, 2008wos wos 37 hacettepe
26 Bilensoy, E, “Nanoparticulate Delivery Systems Based on Amphiphilic Cyclodextrins”, J BIOMED NA, Cilt 4, Baskı 3, Sayfa 293-303, 2008wos wos 12 hacettepe
27 Bilensoy, E; Cirpanli, Y; Sen, M; Dogan, AL; Calis, S, “Thermosensitive mucoadhesive gel formulation loaded with 5-Fu: cyclodextrin complex for HPV-induced cervical cancer”, J INCL P MA, Cilt 57, Baskı 1, Sayfa 363-370, 2007wos wos 25 hacettepe
28 Bilensoy, E; Dogan, L; Sen, M; Hincal, A, “Complexation behavior of antiestrogen drug tamoxifen citrate with natural and modified beta-cyclodextrins”, J INCL P MA, Cilt 57, Baskı 1, Sayfa 651-655, 2007wos wos 17 hacettepe
29 Memisoglu-Bilensoy, E; Hincal, AA, “Sterile, injectable cyclodextrin nanoparticles: Effects of gamma irradiation and autoclaving”, INT J PHARM, Cilt 311, Baskı 1, Sayfa 203-208, 2006wos wos 28 hacettepe
30 Bilensoy, E; Rouf, MA; Vural, I; Sen, M; Hincal, AA, “Mucoadhesive, thermosensitive, prolonged-release vaginal gel for clotrimazole: beta-cyclodextrin complex”, AAPS PHARMS, Cilt 7, Baskı 2, Sayfa 0-0, 2006 wos 26 hacettepe
31 Memisoglu-Bilensoy, E; Vural, L; Bochot, A; Renoir, JM; Duchene, D; Hincal, AA, “Tarnoxifen citrate loaded amphiphilic beta-cyclodextrin nanoparticles: In vitro characterization and cytotoxicity”, J CONTR REL, Cilt 104, Baskı 3, Sayfa 489-496, 2005wos wos 69 hacettepe